vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and MINERALS TECHNOLOGIES INC (MTX). Click either name above to swap in a different company.

MINERALS TECHNOLOGIES INC is the larger business by last-quarter revenue ($519.5M vs $270.8M, roughly 1.9× HUTCHMED (China) Ltd). MINERALS TECHNOLOGIES INC runs the higher net margin — 7.2% vs 0.7%, a 6.4% gap on every dollar of revenue. On growth, MINERALS TECHNOLOGIES INC posted the faster year-over-year revenue change (0.3% vs -16.5%). MINERALS TECHNOLOGIES INC produced more free cash flow last quarter ($31.9M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Compass Minerals International, Inc is an American public company that, through its subsidiaries, is a leading producer of minerals, including salt, magnesium chloride and sulfate of potash. Based in Overland Park, Kansas; the company provides bulk treated and untreated highway deicing salt to customers in North America and the United Kingdom and plant nutrition products to growers worldwide. Compass Minerals also produces consumer deicing and water conditioning products, consumer and commerc...

HCM vs MTX — Head-to-Head

Bigger by revenue
MTX
MTX
1.9× larger
MTX
$519.5M
$270.8M
HCM
Growing faster (revenue YoY)
MTX
MTX
+16.8% gap
MTX
0.3%
-16.5%
HCM
Higher net margin
MTX
MTX
6.4% more per $
MTX
7.2%
0.7%
HCM
More free cash flow
MTX
MTX
$28.5M more FCF
MTX
$31.9M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
MTX
MTX
Revenue
$270.8M
$519.5M
Net Profit
$2.0M
$37.2M
Gross Margin
37.7%
24.0%
Operating Margin
-13.2%
11.9%
Net Margin
0.7%
7.2%
Revenue YoY
-16.5%
0.3%
Net Profit YoY
-83.6%
-31.1%
EPS (diluted)
$0.00
$1.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
MTX
MTX
Q4 25
$270.8M
$519.5M
Q3 25
$532.4M
Q2 25
$277.7M
$528.9M
Q1 25
$324.5M
$491.8M
Q4 24
$518.1M
Q3 24
$524.7M
Q2 24
$305.7M
$541.2M
Q1 24
$534.5M
Net Profit
HCM
HCM
MTX
MTX
Q4 25
$2.0M
$37.2M
Q3 25
$43.0M
Q2 25
$455.0M
$45.4M
Q1 25
$11.9M
$-144.0M
Q4 24
$54.0M
Q3 24
$46.7M
Q2 24
$25.8M
$19.7M
Q1 24
$46.7M
Gross Margin
HCM
HCM
MTX
MTX
Q4 25
37.7%
24.0%
Q3 25
25.7%
Q2 25
0.1%
25.9%
Q1 25
48.0%
24.3%
Q4 24
25.6%
Q3 24
25.8%
Q2 24
41.1%
26.6%
Q1 24
25.4%
Operating Margin
HCM
HCM
MTX
MTX
Q4 25
-13.2%
11.9%
Q3 25
13.3%
Q2 25
-1.3%
14.1%
Q1 25
-5.0%
-32.6%
Q4 24
16.2%
Q3 24
14.6%
Q2 24
-9.0%
9.3%
Q1 24
14.1%
Net Margin
HCM
HCM
MTX
MTX
Q4 25
0.7%
7.2%
Q3 25
8.1%
Q2 25
163.8%
8.6%
Q1 25
3.7%
-29.3%
Q4 24
10.4%
Q3 24
8.9%
Q2 24
8.4%
3.6%
Q1 24
8.7%
EPS (diluted)
HCM
HCM
MTX
MTX
Q4 25
$0.00
$1.11
Q3 25
$1.37
Q2 25
$0.52
$1.44
Q1 25
$0.01
$-4.51
Q4 24
$1.67
Q3 24
$1.45
Q2 24
$0.03
$0.61
Q1 24
$1.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
MTX
MTX
Cash + ST InvestmentsLiquidity on hand
$1.4B
$332.6M
Total DebtLower is stronger
$93.2M
$961.3M
Stockholders' EquityBook value
$1.2B
$1.7B
Total Assets
$1.8B
$3.5B
Debt / EquityLower = less leverage
0.08×
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
MTX
MTX
Q4 25
$1.4B
$332.6M
Q3 25
$328.3M
Q2 25
$1.4B
$319.9M
Q1 25
$836.1M
$312.2M
Q4 24
$337.1M
Q3 24
$324.5M
Q2 24
$802.5M
$316.4M
Q1 24
$320.1M
Total Debt
HCM
HCM
MTX
MTX
Q4 25
$93.2M
$961.3M
Q3 25
$964.3M
Q2 25
$93.4M
$965.6M
Q1 25
$82.8M
$966.7M
Q4 24
$966.1M
Q3 24
$922.9M
Q2 24
$82.1M
$922.4M
Q1 24
$925.8M
Stockholders' Equity
HCM
HCM
MTX
MTX
Q4 25
$1.2B
$1.7B
Q3 25
$1.7B
Q2 25
$1.2B
$1.7B
Q1 25
$759.9M
$1.6B
Q4 24
$1.7B
Q3 24
$1.7B
Q2 24
$740.1M
$1.7B
Q1 24
$1.7B
Total Assets
HCM
HCM
MTX
MTX
Q4 25
$1.8B
$3.5B
Q3 25
$3.5B
Q2 25
$1.8B
$3.5B
Q1 25
$1.3B
$3.4B
Q4 24
$3.4B
Q3 24
$3.4B
Q2 24
$1.3B
$3.3B
Q1 24
$3.3B
Debt / Equity
HCM
HCM
MTX
MTX
Q4 25
0.08×
0.56×
Q3 25
0.58×
Q2 25
0.08×
0.58×
Q1 25
0.11×
0.60×
Q4 24
0.55×
Q3 24
0.54×
Q2 24
0.11×
0.55×
Q1 24
0.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
MTX
MTX
Operating Cash FlowLast quarter
$8.2M
$64.3M
Free Cash FlowOCF − Capex
$3.4M
$31.9M
FCF MarginFCF / Revenue
1.2%
6.1%
Capex IntensityCapex / Revenue
1.8%
6.2%
Cash ConversionOCF / Net Profit
4.21×
1.73×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$86.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
MTX
MTX
Q4 25
$8.2M
$64.3M
Q3 25
$70.9M
Q2 25
$-72.9M
$62.9M
Q1 25
$40.3M
$-4.4M
Q4 24
$70.4M
Q3 24
$60.0M
Q2 24
$-39.8M
$50.1M
Q1 24
$55.9M
Free Cash Flow
HCM
HCM
MTX
MTX
Q4 25
$3.4M
$31.9M
Q3 25
$43.6M
Q2 25
$-82.2M
$33.8M
Q1 25
$32.5M
$-22.7M
Q4 24
$42.3M
Q3 24
$35.3M
Q2 24
$-49.9M
$29.9M
Q1 24
$39.4M
FCF Margin
HCM
HCM
MTX
MTX
Q4 25
1.2%
6.1%
Q3 25
8.2%
Q2 25
-29.6%
6.4%
Q1 25
10.0%
-4.6%
Q4 24
8.2%
Q3 24
6.7%
Q2 24
-16.3%
5.5%
Q1 24
7.4%
Capex Intensity
HCM
HCM
MTX
MTX
Q4 25
1.8%
6.2%
Q3 25
5.1%
Q2 25
3.3%
5.5%
Q1 25
2.4%
3.7%
Q4 24
5.4%
Q3 24
4.7%
Q2 24
3.3%
3.7%
Q1 24
3.1%
Cash Conversion
HCM
HCM
MTX
MTX
Q4 25
4.21×
1.73×
Q3 25
1.65×
Q2 25
-0.16×
1.39×
Q1 25
3.38×
Q4 24
1.30×
Q3 24
1.28×
Q2 24
-1.54×
2.54×
Q1 24
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

MTX
MTX

High Temperature Technologies$178.0M34%
Specialty Additives$141.8M27%
Household And Personal Care$132.5M26%
Environmental And Infrastructure$67.2M13%

Related Comparisons